Ebru Kayra
Research Subjects
Ebru Kayra has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Baris Mantoglu
Department of General Surgery, Sakarya University Training and Research Hospital, Sakarya
2 shared publications - Emre Gönüllü
Sakarya Egitim ve Araştırma hastanesi
2 shared publications - Fatih Altintoprak
Faculty of Medicine, Department of General Surgery, Sakarya University, Sakarya, Turkey
2 shared publications - Kayhan Ozdemir
Department of General Surgery, Sakarya University Faculty of Medicine, Sakarya, Turkey
2 shared publications - Ali Muhtaroğlu
Department of General Surgery, Giresun University Faculty of Medicine, Giresun, Turkey
1 shared publication - Belma Kocer
Department of General Surgery, Sakarya University Faculty of Medicine, Sakarya, Turkey
1 shared publication
Latest Publications
- 1 July 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (7) , 756-759
Primary ovarian leiomyoma: an unlikely differential diagnosis of adnex
Introduction Primary ovarian leiomyoma is a rare benign ovarian tumor seen in women aged 20 to 65 years. It is generally asymptomatic and is often incidentally diagnosed during pelvic imaging or after pathological examination following surgery. Case Presentation A 47-year-old patient with secondary infertility presented to the hospital with complaints of abnormal uterine bleeding and abdominal pain. Imaging suggested a diagnosis consistent with thecoma/fibroma. During the total abdominal hysterectomy and bilateral salpingo-oophorectomy surgery, macroscopic and microscopic examination of the specimen sent for pathological evaluation led to the diagnosis of primary ovarian leiomyoma. Conclusion This case highlights the importance of considering paraovarian and intraovarian leiomyomas in the differential diagnosis of pelvic masses. Preoperative imaging, including high-resolution ultrasound (US) and computed tomography (CT), plays a critical role in the initial evaluation of these masses, while laparotomy and histopathological examination are necessary for definitive diagnosis and treatment.
- 1 July 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (7) , 756-759
Primary ovarian leiomyoma: an unlikely differential diagnosis of adnex
Introduction Primary ovarian leiomyoma is a rare benign ovarian tumor seen in women aged 20 to 65 years. It is generally asymptomatic and is often incidentally diagnosed during pelvic imaging or after pathological examination following surgery. Case Presentation A 47-year-old patient with secondary infertility presented to the hospital with complaints of abnormal uterine bleeding and abdominal pain. Imaging suggested a diagnosis consistent with thecoma/fibroma. During the total abdominal hysterectomy and bilateral salpingo-oophorectomy surgery, macroscopic and microscopic examination of the specimen sent for pathological evaluation led to the diagnosis of primary ovarian leiomyoma. Conclusion This case highlights the importance of considering paraovarian and intraovarian leiomyomas in the differential diagnosis of pelvic masses. Preoperative imaging, including high-resolution ultrasound (US) and computed tomography (CT), plays a critical role in the initial evaluation of these masses, while laparotomy and histopathological examination are necessary for definitive diagnosis and treatment.
- Open Access
- 1 January 2022
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 13 (04) , 410-414
Single center experiences in merkel cell carcinoma and unprecedented presentation
- 1 January 2022
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 13 (04) , 410-414
Open AccessSingle center experiences in merkel cell carcinoma and unprecedented presentation
- Open Access
- 1 November 2021
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 24 (11) , 852-855
Coexistence of Neurofibromatosis Type 1 and Male Breast Cancer
Breast cancer is one of the rarest types of cancer in men. Its incidence increases with age, as in women. Neurofibromatosis type 1 is an autosomal dominant genetic disease that predisposes to many cancer types. Neurofibromatosis and breast cancer have been more frequently distinguished and better studied in women. Characteristically, estrogen, progesterone receptors, negative, and overexpression of human epidermal growth factor receptor 2 (HER2) are detected in patients with female neurofibromatosis breast cancers. In cases reported so far, estrogen and progesterone receptors have been evaluated as positive and HER2 negative in male patients. With the high possibility of breast cancer development in female patients with neurofibromatosis at an earlier age, prompt and careful evaluation is required in terms of both examination and radiological imaging. Unfortunately, there are no thorough recommendations for breast cancer follow-up in male patients with neurofibromatosis. Here, we present a breast cancer, which is an uncommon type of cancer in male neurofibromatosis.
- 1 November 2021
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 24 (11) , 852-855
Open AccessCoexistence of Neurofibromatosis Type 1 and Male Breast Cancer
Breast cancer is one of the rarest types of cancer in men. Its incidence increases with age, as in women. Neurofibromatosis type 1 is an autosomal dominant genetic disease that predisposes to many cancer types. Neurofibromatosis and breast cancer have been more frequently distinguished and better studied in women. Characteristically, estrogen, progesterone receptors, negative, and overexpression of human epidermal growth factor receptor 2 (HER2) are detected in patients with female neurofibromatosis breast cancers. In cases reported so far, estrogen and progesterone receptors have been evaluated as positive and HER2 negative in male patients. With the high possibility of breast cancer development in female patients with neurofibromatosis at an earlier age, prompt and careful evaluation is required in terms of both examination and radiological imaging. Unfortunately, there are no thorough recommendations for breast cancer follow-up in male patients with neurofibromatosis. Here, we present a breast cancer, which is an uncommon type of cancer in male neurofibromatosis.